Back to Forecasting
VIAVActive

Will VIAV insiders sell an additional $5M+ in discretionary shares by June 30, 2026?

Resolves July 31, 2026(131d)
IG: 0.64

Current Prediction

68%
Likely Yes
Model Agreement92%
Predictions9 runs
Last UpdatedMarch 22, 2026

Why This Question Matters

The insider selling cluster is the most concerning governance signal. Seven insiders selling $14.1M in discretionary shares with zero purchases is unusually broad. Whether selling continues at this pace or abates after the initial vesting wave will clarify whether this was routine diversification or a warning about near-term prospects. SVP Global Sales selling during revenue acceleration is particularly notable.

GOVERNANCE_ALIGNMENT

Prediction Distribution

0%25%50%75%100%
opus
sonnet
haiku
Range: 62%75%Aggregate: 68%
Individual Predictions(9 runs)
opusRun 1
72%

The selling cluster was exceptionally broad (7 insiders) and occurred at $24.50-$27.52. The stock is now at ~$33 — significantly higher. Insiders who sold at $25 have even stronger financial incentive to continue selling at $33. The discretionary nature (not 10b5-1) and complete absence of buying suggest this is systematic, not one-time diversification. Restricted stock continues to vest, providing more shares to sell. $5M threshold is modest given prior $14.1M in one quarter.

Stock rose from ~$25 selling price to ~$33 — stronger incentive to sellOngoing RSU vesting provides new shares to sell$5M threshold is modest vs $14.1M prior quarter
opusRun 2
65%

Insider selling tends to cluster and then pause. The Dec-Mar cluster may have represented a coordinated vesting event response. Many executives sell once after a vesting event and then wait. However, the stock being at all-time highs and insider selling being discretionary (not 10b5-1) suggests opportunistic behavior that may recur. The CEO retaining 1.59M shares means there's substantial remaining position to sell from. Base rate for continued selling after an initial cluster is moderate.

Selling clusters often pause after initial burstStock at all-time highs creates continued selling incentiveCEO has 1.59M shares remaining — large position to sell from
opusRun 3
68%

Behavioral analysis: when 7 insiders sell simultaneously without using 10b5-1 plans, the most likely explanation is a shared view that the stock is at or above fair value. This view doesn't change in 3 months — if anything, the stock going higher would reinforce it. Only 3 insiders used 10b5-1 plans for tiny amounts (~31K shares total). The absence of structured selling programs suggests most insiders prefer the flexibility to sell opportunistically. RSU vesting in Q3/Q4 will provide more shares.

Shared insider view on valuation unlikely to change in 3 monthsAbsence of 10b5-1 plans enables continued opportunistic sellingRSU vesting continues providing sellable shares
sonnetRun 1
75%

This is the most confident prediction. 7 insiders sold $14.1M at $24-27. The stock is now $33 — 22-35% higher. The financial incentive to sell more is STRONGER, not weaker. The question only asks for $5M additional — that's roughly 150,000 shares at $33. Given the CEO alone sold 350,000+ shares in the prior quarter, $5M is a low bar. Unless the company implements a trading blackout or insiders adopt 10b5-1 plans restricting their flexibility, continued selling is very likely.

$5M at $33/share = ~150K shares — low bar vs prior 537K sharesStock 22-35% higher than prior selling pricesNo evidence of new trading restrictions or 10b5-1 adoption
sonnetRun 2
62%

High base rate for continued selling, but some counterfactors: Q3 earnings blackout period (typically 2-3 weeks before earnings) limits the selling window to about 9-10 weeks of the 13-week quarter. Some insiders may have reached their target cash-out and stop. The SVP Global Sales selling pattern was particularly notable — if he stops selling, the pool of sellers narrows. Still more likely than not given the broad base and higher stock price.

Earnings blackout period limits selling windowSome insiders may have reached target diversificationHigher stock price maintains selling incentive
sonnetRun 3
70%

The pattern is clear: insiders are monetizing aggressively into the rally. Stock rising from $25 to $33 only amplifies the incentive. The only scenarios where selling pauses: (1) company restricts trading, (2) insiders collectively decide to signal confidence by stopping, (3) stock drops and selling becomes less attractive. None of these are likely in the near term. The $5M threshold is easily reachable — even 2-3 insiders selling modestly would clear it.

Rally amplifies selling incentiveFew plausible scenarios for selling to stop$5M threshold achievable by 2-3 insiders alone
haikuRun 1
70%

Strong historical precedent: 7 insiders selling $14.1M in one quarter at lower prices. Stock now higher. $5M is a low bar. Likely YES.

$14.1M prior quarter sets high baselineStock higher than selling prices$5M is low threshold
haikuRun 2
65%

Insider selling after a major rally is common for tech companies with RSU-heavy compensation. The broad base of 7 sellers and zero buyers creates strong directional signal. Some moderation expected but $5M is easily achievable.

RSU compensation creates ongoing selling supplyBroad seller base — 7 insidersZero buyers counterbalances
haikuRun 3
68%

The base rate for continued insider selling after a cluster is high, especially with the stock at higher prices. Earnings blackout periods provide some constraint but $5M over 3 months is achievable even with limited windows.

High base rate for continued sellingBlackout periods provide modest constraint$5M over 3 months is achievable

Resolution Criteria

Resolves YES if SEC Form 4 filings show VIAV officers or directors selling a cumulative $5M+ in open-market or discretionary stock sales between April 1 and June 30, 2026.

Resolution Source

SEC EDGAR Form 4 filings for VIAV insiders

Source Trigger

7 insiders sold ~$14.1M combined Dec 2025-Mar 2026; monitoring for additional selling or 10b5-1 modifications

insider-investigatorGOVERNANCE_ALIGNMENTHIGH
View VIAV Analysis

Full multi-lens equity analysis